Three Life Science Companies on Venture50 List At its recent venture capital conference in Beijing, Zero2IPO recognized the accomplishments of several early-stage China life science companies, declaring the companies eminently suitable for venture capital investments. The announcements were made at the China Venture Capital Semi-Annual Forum held in Beijing (July 11-12). The event was hosted by Zero2IPO, which provides investment service for venture capital and private equity investment in China, and'sister organization, ChinaBio Accelerator was a co-organizer. More details...